195 related articles for article (PubMed ID: 33134162)
1. Targeted Intraoperative Radiotherapy Is Non-inferior to Conventional External Beam Radiotherapy in Chinese Patients With Breast Cancer: A Propensity Score Matching Study.
Mi Y; Lv P; Wang F; Li L; Zhu M; Wang Y; Zhang Y; Liu L; Cao Q; Dong M; Shi Y; Fan R; Li J; Gu Y; Zuo X
Front Oncol; 2020; 10():550327. PubMed ID: 33134162
[No Abstract] [Full Text] [Related]
2. An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial).
Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Saunders C; Brew-Graves C; Potyka I; Morris S; Vaidya HJ; Williams NR; Baum M
Health Technol Assess; 2016 Sep; 20(73):1-188. PubMed ID: 27689969
[TBL] [Abstract][Full Text] [Related]
3. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial.
Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger HL; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph DJ; Tobias JS
BMJ; 2020 Aug; 370():m2836. PubMed ID: 32816842
[TBL] [Abstract][Full Text] [Related]
4. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.
Vaidya JS; Wenz F; Bulsara M; Tobias JS; Joseph DJ; Keshtgar M; Flyger HL; Massarut S; Alvarado M; Saunders C; Eiermann W; Metaxas M; Sperk E; Sütterlin M; Brown D; Esserman L; Roncadin M; Thompson A; Dewar JA; Holtveg HM; Pigorsch S; Falzon M; Harris E; Matthews A; Brew-Graves C; Potyka I; Corica T; Williams NR; Baum M;
Lancet; 2014 Feb; 383(9917):603-13. PubMed ID: 24224997
[TBL] [Abstract][Full Text] [Related]
5. Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer.
Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Bulsara M; Vaidya JS; Liedtke C
Rev Recent Clin Trials; 2017; 12(2):93-100. PubMed ID: 28155607
[TBL] [Abstract][Full Text] [Related]
6. Prognosis comparison between intraoperative radiotherapy and whole-breast external beam radiotherapy for T1-2 stage breast cancer without lymph node metastasis treated with breast-conserving surgery: A case-control study after propensity score matching.
Chen Q; Qu L; He Y; Xu J; Deng Y; Zhou Q; Yi W
Front Med (Lausanne); 2022; 9():919406. PubMed ID: 35991652
[TBL] [Abstract][Full Text] [Related]
7. Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast Cancer.
Vaidya JS; Bulsara M; Saunders C; Flyger H; Tobias JS; Corica T; Massarut S; Wenz F; Pigorsch S; Alvarado M; Douek M; Eiermann W; Brew-Graves C; Williams N; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Le Blanc-Onfroy M; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McCready D; Hoefer R; Kelemen P; Petralia G; Falzon M; Baum M; Joseph D
JAMA Oncol; 2020 Jul; 6(7):e200249. PubMed ID: 32239210
[TBL] [Abstract][Full Text] [Related]
8. Targeted intraoperative radiotherapy tumour bed boost during breast-conserving surgery after neoadjuvant chemotherapy.
Kolberg HC; Loevey G; Akpolat-Basci L; Stephanou M; Fasching PA; Untch M; Liedtke C; Bulsara M; Vaidya JS
Strahlenther Onkol; 2017 Jan; 193(1):62-69. PubMed ID: 27858093
[TBL] [Abstract][Full Text] [Related]
9. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
[TBL] [Abstract][Full Text] [Related]
10. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer.
Vaidya JS; Bulsara M; Baum M; Wenz F; Massarut S; Pigorsch S; Alvarado M; Douek M; Saunders C; Flyger H; Eiermann W; Brew-Graves C; Williams NR; Potyka I; Roberts N; Bernstein M; Brown D; Sperk E; Laws S; Sütterlin M; Corica T; Lundgren S; Holmes D; Vinante L; Bozza F; Pazos M; Blanc-Onfroy ML; Gruber G; Polkowski W; Dedes KJ; Niewald M; Blohmer J; McReady D; Hoefer R; Kelemen P; Petralia G; Falzon M; Joseph D; Tobias JS
Br J Cancer; 2021 Aug; 125(3):380-389. PubMed ID: 34035435
[TBL] [Abstract][Full Text] [Related]
11. Targeted Intraoperative Radiation Therapy during Breast-Conserving Surgery for Patients with Early Stage Breast Cancer: A Phase II Single Center Prospective Trial.
Martinez C; Meterissian S; Saidi A; Tremblay F; Meguerditchian AN; Fleiszer D; Lambert C; David M; Panet-Raymond V; Abdulkarim B; Hijal T
Adv Radiat Oncol; 2023; 8(5):101236. PubMed ID: 37408681
[TBL] [Abstract][Full Text] [Related]
12. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.
Vaidya JS; Joseph DJ; Tobias JS; Bulsara M; Wenz F; Saunders C; Alvarado M; Flyger HL; Massarut S; Eiermann W; Keshtgar M; Dewar J; Kraus-Tiefenbacher U; Sütterlin M; Esserman L; Holtveg HM; Roncadin M; Pigorsch S; Metaxas M; Falzon M; Matthews A; Corica T; Williams NR; Baum M
Lancet; 2010 Jul; 376(9735):91-102. PubMed ID: 20570343
[TBL] [Abstract][Full Text] [Related]
13. Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT.
Coombs NJ; Coombs JM; Vaidya UJ; Singer J; Bulsara M; Tobias JS; Wenz F; Joseph DJ; Brown DA; Rainsbury R; Davidson T; Adamson DJ; Massarut S; Morgan D; Potyka I; Corica T; Falzon M; Williams N; Baum M; Vaidya JS
BMJ Open; 2016 May; 6(5):e010703. PubMed ID: 27160842
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery.
Vaidya JS; Baum M; Tobias JS; Wenz F; Massarut S; Keshtgar M; Hilaris B; Saunders C; Williams NR; Brew-Graves C; Corica T; Roncadin M; Kraus-Tiefenbacher U; Sütterlin M; Bulsara M; Joseph D
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1091-7. PubMed ID: 20951505
[TBL] [Abstract][Full Text] [Related]
15. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A.
Welzel G; Boch A; Sperk E; Hofmann F; Kraus-Tiefenbacher U; Gerhardt A; Suetterlin M; Wenz F
Radiat Oncol; 2013 Jan; 8():9. PubMed ID: 23294485
[TBL] [Abstract][Full Text] [Related]
16. Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial.
Keshtgar MR; Williams NR; Bulsara M; Saunders C; Flyger H; Cardoso JS; Corica T; Bentzon N; Michalopoulos NV; Joseph DJ
Breast Cancer Res Treat; 2013 Aug; 140(3):519-25. PubMed ID: 23877341
[TBL] [Abstract][Full Text] [Related]
17. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost.
Vaidya JS; Baum M; Tobias JS; Massarut S; Wenz F; Murphy O; Hilaris B; Houghton J; Saunders C; Corica T; Roncadin M; Kraus-Tiefenbacher U; Melchaert F; Keshtgar M; Sainsbury R; Douek M; Harrison E; Thompson A; Joseph D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1335-8. PubMed ID: 17084562
[TBL] [Abstract][Full Text] [Related]
18. Targeted Intraoperative Radiotherapy During Breast-conserving Surgery for Breast Cancer in Patients After Implant Augmentation.
Kolberg HC; Uhl V; Massarut S; Holmes D; Kolberg-Liedtke C; Kelly EW; Lövey G; Vaidya JS
Anticancer Res; 2019 Aug; 39(8):4215-4218. PubMed ID: 31366508
[TBL] [Abstract][Full Text] [Related]
19. Is IORT ready for roll-out?
Esposito E; Anninga B; Honey I; Ross G; Rainsbury D; Laws S; Rinsma S; Douek M
Ecancermedicalscience; 2015; 9():516. PubMed ID: 25793013
[TBL] [Abstract][Full Text] [Related]
20. Targeted intraoperative radiotherapy for breast cancer in patients in whom external beam radiation is not possible.
Keshtgar MR; Vaidya JS; Tobias JS; Wenz F; Joseph D; Stacey C; Metaxas MG; Keller A; Corica T; Williams NR; Baum M
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):31-8. PubMed ID: 20646864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
